Immediate Impact
47 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of Philip Badman being referenced
RADICAL trial: A phase Ib/IIa study to assess the safety and efficacy of AZD4547 in combination with either anastrozole or letrozole in ER positive breast cancer patients progressing on these aromatase inhibitors (AIs).
2017
Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Philip Badman | 41 | 12 | 17 | 72 | 53 | 7 | 131 | |
| Raluca Nedelcu | 34 | 15 | 16 | 120 | 118 | 6 | 187 | |
| T. Tillmanns | 21 | 13 | 21 | 34 | 95 | 10 | 162 | |
| C. Brunell | 32 | 9 | 11 | 136 | 124 | 8 | 203 | |
| Anca Milea | 43 | 22 | 56 | 118 | 29 | 9 | 181 | |
| Claire Hoppenot | 54 | 15 | 26 | 77 | 15 | 9 | 157 | |
| Kirsten B. Moysich | 28 | 4 | 51 | 59 | 72 | 7 | 192 | |
| Brigitte Clavier | 33 | 6 | 19 | 69 | 34 | 7 | 139 | |
| Sabrina Witherby | 80 | 32 | 16 | 18 | 47 | 11 | 181 | |
| Cassandra Nichols | 25 | 6 | 9 | 53 | 60 | 9 | 107 | |
| P.M.L.H. Vencken | 100 | 16 | 70 | 130 | 128 | 6 | 232 |
All Works
Loading papers...